Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments

Chronic stress is common among cancer patients due to the psychological, operative, or pharmaceutical stressors at the time of diagnosis or during the treatment of cancers. The continuous activations of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS), as result...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wentao Tian, Yi Liu, Chenghui Cao, Yue Zeng, Yue Pan, Xiaohan Liu, Yurong Peng, Fang Wu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/4b413687b2cf4b6fb1b2746406af0d90
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4b413687b2cf4b6fb1b2746406af0d90
record_format dspace
spelling oai:doaj.org-article:4b413687b2cf4b6fb1b2746406af0d902021-11-19T07:36:38ZChronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments2296-634X10.3389/fcell.2021.777018https://doaj.org/article/4b413687b2cf4b6fb1b2746406af0d902021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.777018/fullhttps://doaj.org/toc/2296-634XChronic stress is common among cancer patients due to the psychological, operative, or pharmaceutical stressors at the time of diagnosis or during the treatment of cancers. The continuous activations of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS), as results of chronic stress, have been demonstrated to take part in several cancer-promoting processes, such as tumorigenesis, progression, metastasis, and multi-drug resistance, by altering the tumor microenvironment (TME). Stressed TME is generally characterized by the increased proportion of cancer-promoting cells and cytokines, the reduction and malfunction of immune-supportive cells and cytokines, augmented angiogenesis, enhanced epithelial-mesenchymal transition, and damaged extracellular matrix. For the negative effects that these alterations can cause in terms of the efficacies of anti-cancer treatments and prognosis of patients, supplementary pharmacological or psychotherapeutic strategies targeting HPA, SNS, or psychological stress may be effective in improving the prognosis of cancer patients. Here, we review the characteristics and mechanisms of TME alterations under chronic stress, their influences on anti-cancer therapies, and accessory interventions and therapies for stressed cancer patients.Wentao TianWentao TianYi LiuChenghui CaoChenghui CaoYue ZengYue PanXiaohan LiuYurong PengFang WuFang WuFang WuFang WuFrontiers Media S.A.articlechronic stresstumor microenvironmentglucocorticoidcatecholamineanticancer treatmentBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic chronic stress
tumor microenvironment
glucocorticoid
catecholamine
anticancer treatment
Biology (General)
QH301-705.5
spellingShingle chronic stress
tumor microenvironment
glucocorticoid
catecholamine
anticancer treatment
Biology (General)
QH301-705.5
Wentao Tian
Wentao Tian
Yi Liu
Chenghui Cao
Chenghui Cao
Yue Zeng
Yue Pan
Xiaohan Liu
Yurong Peng
Fang Wu
Fang Wu
Fang Wu
Fang Wu
Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
description Chronic stress is common among cancer patients due to the psychological, operative, or pharmaceutical stressors at the time of diagnosis or during the treatment of cancers. The continuous activations of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS), as results of chronic stress, have been demonstrated to take part in several cancer-promoting processes, such as tumorigenesis, progression, metastasis, and multi-drug resistance, by altering the tumor microenvironment (TME). Stressed TME is generally characterized by the increased proportion of cancer-promoting cells and cytokines, the reduction and malfunction of immune-supportive cells and cytokines, augmented angiogenesis, enhanced epithelial-mesenchymal transition, and damaged extracellular matrix. For the negative effects that these alterations can cause in terms of the efficacies of anti-cancer treatments and prognosis of patients, supplementary pharmacological or psychotherapeutic strategies targeting HPA, SNS, or psychological stress may be effective in improving the prognosis of cancer patients. Here, we review the characteristics and mechanisms of TME alterations under chronic stress, their influences on anti-cancer therapies, and accessory interventions and therapies for stressed cancer patients.
format article
author Wentao Tian
Wentao Tian
Yi Liu
Chenghui Cao
Chenghui Cao
Yue Zeng
Yue Pan
Xiaohan Liu
Yurong Peng
Fang Wu
Fang Wu
Fang Wu
Fang Wu
author_facet Wentao Tian
Wentao Tian
Yi Liu
Chenghui Cao
Chenghui Cao
Yue Zeng
Yue Pan
Xiaohan Liu
Yurong Peng
Fang Wu
Fang Wu
Fang Wu
Fang Wu
author_sort Wentao Tian
title Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
title_short Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
title_full Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
title_fullStr Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
title_full_unstemmed Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
title_sort chronic stress: impacts on tumor microenvironment and implications for anti-cancer treatments
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/4b413687b2cf4b6fb1b2746406af0d90
work_keys_str_mv AT wentaotian chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT wentaotian chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT yiliu chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT chenghuicao chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT chenghuicao chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT yuezeng chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT yuepan chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT xiaohanliu chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT yurongpeng chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT fangwu chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT fangwu chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT fangwu chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
AT fangwu chronicstressimpactsontumormicroenvironmentandimplicationsforanticancertreatments
_version_ 1718420257627963392